SGRYNasdaqServices-General Medical & Surgical Hospitals, NECFiscal year ends December 31
Surgery Partners, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$14.71+0.10 (+0.68%)
Close on Oct 19, 2026
- Market cap
- $1.90B
- P/E (TTM)
- –
- Dividend yield
- –
Surgery Partners, Inc. revenue by segment
By business segment
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Surgical Facilities | $3.37B | $3.34B | $3.31B | $3.29B | $3.24B | $3.17B | $3.11B | – | – | – | – | – | 100.0% | +4.0% |
| Ancillary Services | – | – | – | – | – | – | – | $107.50M | $89.30M | $75.00M | $67.50M | $68.70M | – | – |
| Surgical Facility Services | – | – | – | – | – | – | – | $2.88B | $2.80B | $2.72B | $2.68B | $2.65B | – | – |
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Patient service revenues | $3.28B | $3.26B | $3.23B | $3.21B | $3.16B | $3.11B | $3.05B | $2.93B | $2.84B | $2.75B | $2.70B | $2.67B | 97.5% | +3.7% |
| Private insurance | $1.66B | $1.68B | $1.69B | $1.70B | $1.69B | $1.67B | $1.63B | $1.55B | $1.50B | $1.44B | $1.42B | $1.40B | 49.5% | -1.4% |
| Government | $1.45B | $1.42B | $1.38B | $1.35B | $1.32B | $1.28B | $1.26B | $1.22B | $1.18B | $1.14B | $1.13B | – | 43.2% | +10.4% |
| Self-pay | $88.80M | $87.20M | $87.60M | $90.60M | $83.80M | $82.60M | $82.30M | $78.70M | $75.90M | $72.30M | $68.10M | $66.30M | 2.6% | +6.0% |
| Other service revenues | $84.40M | $83.60M | $82.40M | $79.20M | $73.40M | $65.40M | $59.90M | $55.00M | $49.60M | $45.20M | $42.90M | $41.30M | 2.5% | +15.0% |
| Other | $74.60M | $71.90M | $71.20M | $73.70M | $74.80M | $76.20M | $81.10M | $82.60M | $87.30M | $89.10M | $85.60M | $85.30M | 2.2% | -0.3% |
By region
From the segment and revenue-disaggregation notes of Surgery Partners's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.